Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2006 2
2008 1
2009 1
2011 1
2014 1
2015 6
2016 2
2017 1
2018 2
2019 2
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Treating diabetes mellitus in older and oldest old patients.
Abbatecola AM, Paolisso G, Sinclair AJ. Abbatecola AM, et al. Curr Pharm Des. 2015;21(13):1665-71. doi: 10.2174/1381612821666150130120747. Curr Pharm Des. 2015. PMID: 25633119 Review.
The frailty syndrome is considered one of the most important limitations when treating octogenarians with type 2 diabetes in polypharmacy. Due to the lack of evidence for specific targets of glucose and glycated hemoglobin (A1C) levels in the el …
The frailty syndrome is considered one of the most important limitations when treating octogenarians with type 2 diabetes in polyp …
Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
Thompson AM, Linnebur SA, Vande Griend JP, Saseen JJ. Thompson AM, et al. Consult Pharm. 2014 Feb;29(2):110-23. doi: 10.4140/TCP.n.2014.110. Consult Pharm. 2014. PMID: 24513421 Review.
OBJECTIVE: To review the optimal management of type 2 diabetes mellitus (T2DM) in the older adult. DATA SOURCES: A PubMed search was completed to identify publications in the English language from 1947 to 2013 using combinations of the search terms: ge …
OBJECTIVE: To review the optimal management of type 2 diabetes mellitus (T2DM) in the older adult. DATA SOURCES: …
Management of Patients With Stable Angina and Type 2 Diabetes.
Deedwania PC. Deedwania PC. Rev Cardiovasc Med. 2015;16(2):105-13. doi: 10.3909/ricm0742. Rev Cardiovasc Med. 2015. PMID: 26198557 Review.
Type 2 diabetes (T2D) is a well-established risk factor for patients with coronary artery disease (CAD). ...At the same time, there is significant concern about the preservation of glycometabolic parameters, such as glycosylated hemoglobin (HbA1c), particularly beca …
Type 2 diabetes (T2D) is a well-established risk factor for patients with coronary artery disease (CAD). ...At the same time, there i …
Glycemic control and prevention of microvascular and macrovascular disease in the Steno 2 study.
Vaag AA. Vaag AA. Endocr Pract. 2006 Jan-Feb;12 Suppl 1:89-92. doi: 10.4158/EP.12.S1.89. Endocr Pract. 2006. PMID: 16627389 Review.
RESULTS: Intensive and target-driven behavior modeling and polypharmacy for 7.8 years induced an absolute risk reduction of 20% in cardiovascular disease events in patients with type 2 diabetes and the metabolic syndrome in comparison with a conventional multifactor …
RESULTS: Intensive and target-driven behavior modeling and polypharmacy for 7.8 years induced an absolute risk reduction of 20% in ca …
Special considerations for treatment of type 2 diabetes mellitus in the elderly.
Fravel MA, McDanel DL, Ross MB, Moores KG, Starry MJ. Fravel MA, et al. Am J Health Syst Pharm. 2011 Mar 15;68(6):500-9. doi: 10.2146/ajhp080085. Am J Health Syst Pharm. 2011. PMID: 21378298 Review.
PURPOSE: The intensity and selection of therapy for the treatment of type 2 diabetes mellitus in elderly patients are discussed. SUMMARY: Glycemic control is fundamental in diabetes care; however, as glycemic goals are approached, the ris …
PURPOSE: The intensity and selection of therapy for the treatment of type 2 diabetes mellitus in elderly patient …
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics.
Ramadan WH, Kabbara WK. Ramadan WH, et al. Vasc Health Risk Manag. 2015 Feb 11;11:125-32. doi: 10.2147/VHRM.S79198. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 25709467 Free PMC article. Review.
RESULTS: When compared with glipizide as add-on therapy to metformin, sitagliptin was noninferior but had lower rates of hypoglycemia and weight gain. In addition, when compared with insulin glargine, sitagliptin was less effective in decreasing glycosylated hemoglobin …
RESULTS: When compared with glipizide as add-on therapy to metformin, sitagliptin was noninferior but had lower rates of hypoglycemia and we …
Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?
Mathur S, Zammitt NN, Frier BM. Mathur S, et al. Drug Saf. 2015 Jan;38(1):17-32. doi: 10.1007/s40264-014-0247-7. Drug Saf. 2015. PMID: 25481812 Review.
The global prevalence of type 2 diabetes mellitus (T2DM) is rising in an ageing population through a combination of lifestyle changes and greater longevity. ...While diabetes per se has a significant impact on the elderly person, the side effect …
The global prevalence of type 2 diabetes mellitus (T2DM) is rising in an ageing population through a combination …
Factors Associated with Long-Term Control of Type 2 Diabetes Mellitus.
Badedi M, Solan Y, Darraj H, Sabai A, Mahfouz M, Alamodi S, Alsabaani A. Badedi M, et al. J Diabetes Res. 2016;2016:2109542. doi: 10.1155/2016/2109542. Epub 2016 Dec 20. J Diabetes Res. 2016. PMID: 28090538 Free PMC article.
Aims. This study assessed factors associated with glycemic control among Saudi patients with Type 2 diabetes mellitus (T2DM). ...Results. More than two-thirds (74%) of patients had poor glycemic control. Lack of education, polypharmacy …
Aims. This study assessed factors associated with glycemic control among Saudi patients with Type 2 diabetes …
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.
Lipska KJ, Krumholz H, Soones T, Lee SJ. Lipska KJ, et al. JAMA. 2016 Mar 8;315(10):1034-45. doi: 10.1001/jama.2016.0299. JAMA. 2016. PMID: 26954412 Free PMC article. Review.
IMPORTANCE: There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes mellitus. OBSERVATIONS: Four large randomized clinical trials (RCTs), ranging in size from 1791 to 11,440 patients, provide the majo …
IMPORTANCE: There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes …
An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment.
Butt MD, Ong SC, Rafiq A, Malik T, Sajjad A, Batool N, Chughtai AUH, Wahab MU, Abdullah M, Babar ZU. Butt MD, et al. Sci Rep. 2023 Dec 27;13(1):23037. doi: 10.1038/s41598-023-50517-2. Sci Rep. 2023. PMID: 38155289 Free PMC article.
In 2021, the International Diabetes Federation (IDF) reported that the prevalence of diabetes in Pakistan was 9.6%, higher than the global average. ...The study reveals that Pakistan's prescribing practices do not align with international and national guidelines, le …
In 2021, the International Diabetes Federation (IDF) reported that the prevalence of diabetes in Pakistan was 9.6%, higher tha …
24 results